FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4293760988> ?p ?o ?g. }

• W4293760988 endingPage "144" @default.
• W4293760988 startingPage "137" @default.
• W4293760988 abstract "Introduction: Plasma cell leukemia (PL) is a rare lymphoproliferative disorder characterized by the monoclonal proliferation of plasma cells in the marrow and blood peripheral. It is defined by a blood plasmacytosis greater than 2 G/l or a plasma cell level greater than 20% of leukocytes. It can be primitive or secondary to multiple myeloma (MM). We reported 3 cases of PL. Observations: Case 1: A 59 years old woman with fever, anemia with 7 g/dl, hyperleukocytosis 9200/mm3, thrombopenia 86 G/l inflammatory biological syndrome with CRP at 129 mg/l, hypercalcemia at 120 mg/l, renal failure with serum creatinine at 35 mg/l, urea at 0.85 g/l and 24-hour proteinuria at 0.98 g/24h. Β2 microglobulin at 10.34 mg/l. The blood smear shows dysmorphic plasma cells at 68% and the bone marrow at 79% of dysmorphic plasma cells. The immunophenotyping of blood cells, the electrophoretic serum protein, shows PL CD38+, secondary of a MM LAMBDA. Case 2: A 65-year-old man with type 2 diabetes presented, right femoral neck, anemia, hyperleukocytosis at 22 G/l, and thrombocytopenia at 99 G/l. There was no hypercalcemia, or kidney failure. The blood smear showed 28% of plasma cells and 9% of blasts. On the myelogram, the marrow was normal richness with significant medullary plasmacytosis (31%) made up of dysmorphic plasma cells. The CT scan showed a settling of the body of D5 with heterogeneous osteocondensation. The patient was transferred to hematology where she was treated with polychemotherapy. The evolution was unfavorable following a death due to malignant hypercalcemia. Case 3: A 62-year-old woman who had a 5-year follow-up of Ig G kappa multiple myeloma was treated with Melphalan, Prednisone, and thalidomide with a therapeutic break for 2 months. She came back to the Internal Medicine department with: severe global dehydration, anemia with externalized bleeding gingivorrhagia, pain in mechanical bones of the ribs, lower limbs, and pelvis, bilateral pneumonia. The biology found hyperleukocytosis at 99 G/l, anemia at 4.7 g/dl, thrombocytopenia at 31 g/l, hypercalcemia at 190 mg/l, renal failure with creatinine at 34 mg/L, and urea at 1.08 g/l, a biological inflammatory syndrome with CRP 294 mg/l. The smeared blood had shown 93% blood plasma cells and immunophenotyping showed CD38+. The patient died before specific treatment for the disease. Conclusion: Plasma cell leukemia is a rare atypical variant, complicating essentially multiple light chain myeloma. She must be suspected especially when there are cytological abnormalities such as major leukocytosis or thrombocytopenia, which are unusual in classical myeloma. Evolution is usually a very bad prognosis, with a median survival of 12 to 14 months for the form primary and 2 to 3 months for the secondary form." @default.
• W4293760988 created "2022-08-31" @default.
• W4293760988 creator A5000233667 @default.
• W4293760988 creator A5001524397 @default.
• W4293760988 creator A5007718117 @default.
• W4293760988 creator A5016310702 @default.
• W4293760988 creator A5019122460 @default.
• W4293760988 creator A5035807827 @default.
• W4293760988 creator A5051592967 @default.
• W4293760988 creator A5051844743 @default.
• W4293760988 creator A5053650500 @default.
• W4293760988 creator A5059098315 @default.
• W4293760988 creator A5059446116 @default.
• W4293760988 creator A5061390399 @default.
• W4293760988 creator A5061931765 @default.
• W4293760988 creator A5070003416 @default.
• W4293760988 creator A5072305394 @default.
• W4293760988 creator A5078096365 @default.
• W4293760988 date "2022-01-01" @default.
• W4293760988 modified "2023-10-18" @default.
• W4293760988 title "Three Cases of Plasma Cell Leukemia" @default.
• W4293760988 cites W1970547637 @default.
• W4293760988 cites W1972823776 @default.
• W4293760988 cites W1975743061 @default.
• W4293760988 cites W1983415557 @default.
• W4293760988 cites W1992984993 @default.
• W4293760988 cites W2002324468 @default.
• W4293760988 cites W2003426156 @default.
• W4293760988 cites W2029070213 @default.
• W4293760988 cites W2054970678 @default.
• W4293760988 cites W2070653024 @default.
• W4293760988 cites W2081643520 @default.
• W4293760988 cites W2082169216 @default.
• W4293760988 cites W2092433443 @default.
• W4293760988 cites W2094751201 @default.
• W4293760988 cites W2095561966 @default.
• W4293760988 cites W2103282571 @default.
• W4293760988 cites W2111566607 @default.
• W4293760988 cites W2135530131 @default.
• W4293760988 cites W2549296307 @default.
• W4293760988 cites W78262064 @default.
• W4293760988 doi "https://doi.org/10.4236/ojim.2022.123016" @default.
• W4293760988 hasPublicationYear "2022" @default.
• W4293760988 type Work @default.
• W4293760988 citedByCount "0" @default.
• W4293760988 crossrefType "journal-article" @default.
• W4293760988 hasAuthorship W4293760988A5000233667 @default.
• W4293760988 hasAuthorship W4293760988A5001524397 @default.
• W4293760988 hasAuthorship W4293760988A5007718117 @default.
• W4293760988 hasAuthorship W4293760988A5016310702 @default.
• W4293760988 hasAuthorship W4293760988A5019122460 @default.
• W4293760988 hasAuthorship W4293760988A5035807827 @default.
• W4293760988 hasAuthorship W4293760988A5051592967 @default.
• W4293760988 hasAuthorship W4293760988A5051844743 @default.
• W4293760988 hasAuthorship W4293760988A5053650500 @default.
• W4293760988 hasAuthorship W4293760988A5059098315 @default.
• W4293760988 hasAuthorship W4293760988A5059446116 @default.
• W4293760988 hasAuthorship W4293760988A5061390399 @default.
• W4293760988 hasAuthorship W4293760988A5061931765 @default.
• W4293760988 hasAuthorship W4293760988A5070003416 @default.
• W4293760988 hasAuthorship W4293760988A5072305394 @default.
• W4293760988 hasAuthorship W4293760988A5078096365 @default.
• W4293760988 hasBestOaLocation W42937609881 @default.
• W4293760988 hasConcept C126322002 @default.
• W4293760988 hasConcept C142724271 @default.
• W4293760988 hasConcept C2776364478 @default.
• W4293760988 hasConcept C2778248108 @default.
• W4293760988 hasConcept C2778461978 @default.
• W4293760988 hasConcept C2778709411 @default.
• W4293760988 hasConcept C2778923028 @default.
• W4293760988 hasConcept C2780007613 @default.
• W4293760988 hasConcept C2780353925 @default.
• W4293760988 hasConcept C71924100 @default.
• W4293760988 hasConcept C90924648 @default.
• W4293760988 hasConceptScore W4293760988C126322002 @default.
• W4293760988 hasConceptScore W4293760988C142724271 @default.
• W4293760988 hasConceptScore W4293760988C2776364478 @default.
• W4293760988 hasConceptScore W4293760988C2778248108 @default.
• W4293760988 hasConceptScore W4293760988C2778461978 @default.
• W4293760988 hasConceptScore W4293760988C2778709411 @default.
• W4293760988 hasConceptScore W4293760988C2778923028 @default.
• W4293760988 hasConceptScore W4293760988C2780007613 @default.
• W4293760988 hasConceptScore W4293760988C2780353925 @default.
• W4293760988 hasConceptScore W4293760988C71924100 @default.
• W4293760988 hasConceptScore W4293760988C90924648 @default.
• W4293760988 hasIssue "03" @default.
• W4293760988 hasLocation W42937609881 @default.
• W4293760988 hasOpenAccess W4293760988 @default.
• W4293760988 hasPrimaryLocation W42937609881 @default.
• W4293760988 hasRelatedWork W1971636731 @default.
• W4293760988 hasRelatedWork W2005843898 @default.
• W4293760988 hasRelatedWork W2040599493 @default.
• W4293760988 hasRelatedWork W2099429225 @default.
• W4293760988 hasRelatedWork W2346131964 @default.
• W4293760988 hasRelatedWork W2359090054 @default.
• W4293760988 hasRelatedWork W2428976267 @default.
• W4293760988 hasRelatedWork W2549296307 @default.
• W4293760988 hasRelatedWork W2565782366 @default.

• next